Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

More articles from Clinical (Oncology: Other)

  • You have access
    A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806
    Hui K Gan, Matthew Burge, Benjamin Solomon, SzeTing Lee, Kyle D Holen, Yumin Zhang, Marika Ciprotti, FT Lee, Wijth Manusinghe, Judee Fischer, Peter Ansell, Gerard Fox, Hao Xiong, Edward B Reilly, Rod Humerickhouse and Andrew M Scott
    Journal of Nuclear Medicine January 28, 2021, jnumed.120.253146; DOI: https://doi.org/10.2967/jnumed.120.253146
  • You have access
    Radioguided Surgery (Letter to the Editor)
    Giuliano Mariani, Renato A. Valdés Olmos, Sergi Vidal-Sicart and Harry William Strauss
    Journal of Nuclear Medicine January 15, 2021, jnumed.120.261888; DOI: https://doi.org/10.2967/jnumed.120.261888
  • You have access
    Pharmacogenomics in Radionuclide Therapy: Impact on Response to Theranostics
    Andrew Scott and Lisa Bodei
    Journal of Nuclear Medicine December 31, 2020, jnumed.120.254995; DOI: https://doi.org/10.2967/jnumed.120.254995
  • You have access
    11C-sorafenib and 15O-H2O PET for early evaluation of sorafenib therapy
    Lemonitsa H. Mammatas, Maqsood Yaqub, N. Harry Hendrikse, Otto S. Hoekstra, Richard J. Honeywell, Robert C. Schuit, Martijn R. Meijerink, Lothar A. Schwarte, Godefridus J. Peters, Henk M.W. Verheul, Adriaan A. Lammertsma and C. Willemien Menke-van der Houven van Oordt
    Journal of Nuclear Medicine October 30, 2020, jnumed.120.251611; DOI: https://doi.org/10.2967/jnumed.120.251611
  • You have access
    PET/MRI versus PET/CT for Whole-Body Staging
    Stephen K Gerard
    Journal of Nuclear Medicine October 9, 2020, jnumed.120.256453; DOI: https://doi.org/10.2967/jnumed.120.256453
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire